Real-World use of a clotting factor drug in iraqi hemophilia patients under review
NCT ID NCT06574984
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 21 times
Summary
This study observes how turoctocog alfa, a clotting factor medicine, is actually used in routine care for people with hemophilia A in Iraq. Researchers will review medical records from about 900 male patients to track bleeding rates and treatment patterns. The study does not change how patients are treated—it simply collects existing data to better understand real-world management.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Basrah Haemoplhilia centre
NOT_YET_RECRUITINGBasra, 61001, Iraq
-
Hilla Haemophilia centre
ENROLLING_BY_INVITATIONHillah, 51001, Iraq
-
Karbala Haemophilia centre
ENROLLING_BY_INVITATIONKarbala, 56001, Iraq
-
Kirkuk Centre for Cancer and Blood Disorders
ENROLLING_BY_INVITATIONKirkuk, 36001, Iraq
-
Najaf Haemophilia Centre
ENROLLING_BY_INVITATIONNajaf, 54001, Iraq
-
National centre for Hamophilia
ENROLLING_BY_INVITATIONBaghdad, 10001, Iraq
-
Novo Nordisk Investigational Site
RECRUITINGBaghdad, Iraq
Conditions
Explore the condition pages connected to this study.